PARIS (dpa-AFX) - Sanofi (SNYNF, SNY) announced a number of changes to the company's Executive Committee, supporting its recently announced 2020 Strategic Roadmap. As of June 1, 2016, the company's Executive Committee, chaired by Olivier Brandicourt, will be comprised of: Olivier Charmeil, Jérôme Contamine, Peter Guenter, Carsten Hellmann, Karen Linehan, David Loew, Philippe Luscan, Muzammil Mansuri, David Meeker, Ameet Nathwani, Roberto Pucci and Elias Zerhouni.
Sanofi also announced that Pascale Witz, Executive Vice President, Diabetes & Cardiovascular, will leave the company on June 1. Carsten Hellmann, Executive Vice President, Merial, has accepted a position as President and CEO of ALK but will stay with Sanofi until the end of the year.
Sanofi said it plans to name at a later date an Executive Vice President, Consumer Healthcare who will be a member of the Executive Committee.
The company said, Suresh Kumar, Executive Vice President, External Affairs, has decided to return to the United States for personal reasons. Suresh has agreed to continue to represent Sanofi's interest in the U.S. until the year-end.
Copyright RTT News/dpa-AFX